Journal of the American College of Cardiology
-
J. Am. Coll. Cardiol. · Feb 2004
Multicenter Study Clinical TrialPredischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.
The aim of this study was to determine the value of serial B-type natriuretic peptide (BNP) assay for predicting post-discharge outcome of patients admitted for decompensated congestive heart failure (CHF). ⋯ High predischarge BNP assay is a strong, independent marker of death or re-admission after decompensated CHF, more relevant than common clinical or echocardiographic parameters and more relevant than changes in BNP levels during acute cares.